Quantification of the concentration gradient of biomarkers between ovarian carcinoma interstitial fluid and blood

AbstractBackgroundTumor interstitial fluid (TIF) rather than plasma should be used in cancer biomarker discovery because of the anticipated higher concentration of locally produced proteins in the tumor microenvironment. Nevertheless, the actual TIF-to-plasma gradient of tumor specific proteins has not been quantified. We present the proof-of-concept for the quantification of the postulated gradient between TIF and plasma.MethodsTIF was collected by centrifugation from serous (n=19), endometrioid (n=9) and clear cell (n=3) ovarian carcinomas with early (n=15) and late stage (n=16) disease in grades 1 (n=2), 2 (n=8) and 3 (n=17), and ELISA was used for the determination of CA-125, osteopontin and VEGF-A.ResultsAll three markers were significantly up-regulated in TIF compared with plasma (p